More about

Lupus

News
June 12, 2024
2 min read
Save

‘Very important’: Belimumab decreases lupus flare vs placebo in early, established disease

‘Very important’: Belimumab decreases lupus flare vs placebo in early, established disease

Treatment with belimumab resulted in fewer flares in patients with either early or established systemic lupus erythematosus, especially among those with no baseline organ damage, according to data presented at the EULAR 2024 Congress.

News
June 10, 2024
1 min read
Save

Deucravacitinib ‘very likely’ best small molecule for systemic lupus erythematosus

Deucravacitinib ‘very likely’ best small molecule for systemic lupus erythematosus

Deucravacitinib is “very likely to be the best” targeted small-molecule drug for the treatment of systemic lupus erythematosus, according to data published in Arthritis Research & Therapy.

News
June 04, 2024
2 min read
Save

Childhood lupus remission definitions emphasize corticosteroid cessation

Childhood lupus remission definitions emphasize corticosteroid cessation

New definitions of remission specific to childhood systemic lupus erythematosus promote cessation of corticosteroids and could enable combined child-adult treat-to-target studies, according to an analysis published in Clinical Immunology.

News
May 31, 2024
2 min watch
Save

VIDEO: Sunscreen paramount in reducing cutaneous lupus effects

VIDEO: Sunscreen paramount in reducing cutaneous lupus effects

CLEVELAND — While new treatments for cutaneous lupus are on the horizon, sunscreen remains the best way to offset effects, according to J. Michelle Kahlenberg, MD, PhD.

News
May 29, 2024
2 min read
Save

Lupus erythematosus skin disease does not impact severity of systemic lupus

Lupus erythematosus skin disease does not impact severity of systemic lupus

Skin disease manifestations in systemic lupus erythematosus do not have an impact on disease severity, according to a study.

News
May 23, 2024
2 min read
Save

Hydralazine-induced autoimmune conditions may include drug-induced lupus, vasculitis

Hydralazine-induced autoimmune conditions may include drug-induced lupus, vasculitis

LONG BEACH, Calif. — Hydralazine-induced autoimmune conditions may have a varied presentation, including drug-induced lupus or vasculitis, according to a speaker, here.

News
May 23, 2024
2 min read
Save

Serology ‘significantly different’ between membranous vs. proliferative lupus nephritis

Serology ‘significantly different’ between membranous vs. proliferative lupus nephritis

Proteinuria levels are not predictive of membranous lupus nephritis vs. proliferative lupus nephritis, according to data published in Rheumatology.

News
May 21, 2024
2 min read
Save

Simplified lupus infection prediction score more accurate, feasible than previous version

Simplified lupus infection prediction score more accurate, feasible than previous version

The SLE Severe Infection Score-Revised, an updated score for predicting severe infections in systemic lupus erythematosus, is more accurate and feasible than the prior version, according to data published in Lupus Science & Medicine.

News
May 20, 2024
1 min read
Save

FDA approves Benlysta autoinjector for at-home use in children with lupus

FDA approves Benlysta autoinjector for at-home use in children with lupus

The FDA has approved a Benlysta autoinjector for children aged 5 years and older with systemic lupus erythematosus, enabling at-home administration for the first time, according to a press release from the manufacturer.

News
May 14, 2024
2 min read
Save

'Choose wisely': Each biologic for lupus has 'ideal patient profile'

'Choose wisely': Each biologic for lupus has 'ideal patient profile'

DESTIN, Fla. — When choosing between biologic drugs for systemic lupus erythematosus, it is important to know the “ideal patient profile” each is best suited for, according to a speaker at the Congress of Clinical Rheumatology East.

View more